Viewing
|Articles|September 20, 2011

Positive Phase II study results announced

Novagali Pharma has announced positive results from its Phase II trial of the preservative-free cationic emulsion, Catioprost.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME